Risk prediction for poor outcome and death in hospital in-patients with COVID-19: derivation in Wuhan, China and external validation in London, UK
暂无分享,去创建一个
C. Li | B. Guthrie | D. Bean | Honghan Wu | Q. Li | H. Zhang | J. Teo | K. Dhaliwal | Xiaodong Wu | R. Dobson | J. T. Teo | D. Bean | R. Dobson | T. Shi | X. Wu | X. Zhang | K. Wang | J. Sun | P. Zhao | H. Wu | B. Guthrie | T. Shi | Cheng-hong Li | Kun Wang | Jiaxing Sun | Qiang Li | K. Dhaliwal | Xin Zhang | Huayu Zhang | P. Zhao | Kevin Dhaliwal
[1] K. Yuen,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.
[2] C. Akdis,et al. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China , 2020, Allergy.
[3] Chuanming Li,et al. The Clinical and Chest CT Features Associated With Severe and Critical COVID-19 Pneumonia , 2020, Investigative radiology.
[4] Kun Chen,et al. Characteristics of COVID-19 infection in Beijing , 2020, Journal of Infection.
[5] G. Collins,et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement , 2015, BMJ : British Medical Journal.
[6] Eun Ji Kim,et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. , 2020, JAMA.
[7] Jin-Min Yuan,et al. Systematic review and meta-analysis of predictive symptoms and comorbidities for severe COVID-19 infection , 2020, medRxiv.
[8] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[9] Ivan Griffin,et al. COVID-19: combining antiviral and anti-inflammatory treatments , 2020, The Lancet Infectious Diseases.
[10] Yan Zhao,et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.
[11] J. M. Crawford,et al. Targeting potential drivers of COVID-19: Neutrophil extracellular traps , 2020, The Journal of experimental medicine.
[12] Li Dong,et al. Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2 , 2020, Journal of Infection.
[13] Li Tan,et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study , 2020, Signal Transduction and Targeted Therapy.
[14] Xin Zhou,et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China , 2020, The Journal of Emergency Medicine.
[15] J. Xiang,et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.
[16] Development and External Validation of a Prognostic Multivariable Model on Admission for Hospitalized Patients with COVID-19 , 2020 .
[17] S. Wyke,et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study , 2012, The Lancet.
[18] Zunyou Wu,et al. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.
[19] Ke Ma,et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study , 2020, BMJ.
[20] G. Heinze,et al. Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal , 2020, BMJ.